V. Schachinger et al., Prognostic impact of coronary vasodilator dysfunction on adverse long-termoutcome of coronary heart disease, PERFUSION, 13(9), 2000, pp. 423-432
Background Endothelial vasodilator dysfunction is a characteristic feature
of patients at risk for coronary atherosclerosis. Therefore, we prospective
ly investigated whether coronary endothelial dysfunction predicts disease p
rogression and cardiovascular event rates.
Methods and Results: Coronary vasoreactivity was assessed in 147 patients u
sing the endothelium-dependent dilator acetylcholine, sympathetic activatio
n by cold presser testing, dilator responses to increased blood flow, and d
ilation in response to nitroglycerin. Cardiovascular events (cardiovascular
death, unstable angina, myocardial infarction, percutaneous transluminal c
oronary angioplasty, coronary bypass grafting, ischemic stroke, or peripher
al artery revascularization) served as outcome variables over a median foll
ow-up period of 7.7 Sears, Patients suffering from cardiovascular events du
ring follow-up (n=16) had significantly increased vasoconstrictor responses
to acetylcholine infusion (P=0.009) and cold presser testing (P=0.002), as
well as significantly blunted vasodilator responses to increased blood flo
w (P<0.001) and the intracoronary injection of nitroglycerin (P=0.001). Imp
aired endothelial and endothelium-independent coronary vasoreactivity were
associated with a significantly higher incidence of cardiovascular events 6
2 Kaplan-Meier analysis, By multivariate analysis, all tests of coronary va
soreactivity were significant, independent predictors of a poor prognosis,
even after adjustment for traditional cardiovascular risk factors or the pr
esence of atherosclerosis itself,
Conclusions: Coronary endothelial vasodilator dysfunction predicts long-ter
m atherosclerotic disease progression and cardiovascular event rates, Thus,
the assessment of coronary endothelial vasoreactivity can pro tide pivotal
information as both a diagnostic and prognostic tool in patients at risk f
or coronary heart disease.